...
首页> 外文期刊>Alzheimer s Research & Therapy >Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI
【24h】

Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI

机译:使用纵向结构脑MRI的体素分析预测非认知障碍个体的淀粉样蛋白病理

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Magnetic resonance imaging (MRI) has unveiled specific alterations at different stages of Alzheimer’s disease (AD) pathophysiologic continuum constituting what has been established as “AD signature”. To what extent MRI can detect amyloid-related cerebral changes from structural MRI in cognitively unimpaired individuals is still an area open for exploration. Longitudinal 3D-T1 MRI scans were acquired from a subset of the ADNI cohort comprising 403 subjects: 79 controls (Ctrls), 50 preclinical AD (PreAD), and 274 MCI and dementia due to AD (MCI/AD). Amyloid CSF was used as gold-standard measure with established cutoffs ( 2.5?years, and hence, only subjects within this temporal span are used for evaluation (15 Ctrls, 10 PreAD). The longitudinal voxel-based classifier achieved an AUC?=?0.87 (95%CI 0.72–0.97). The brain regions that showed the highest discriminative power to detect amyloid abnormalities were the medial, inferior, and lateral temporal lobes; precuneus; caudate heads; basal forebrain; and lateral ventricles. Our work supports that machine learning applied to longitudinal brain volumetric changes can be used to predict, with high precision, the presence of amyloid abnormalities in cognitively unimpaired subjects. Used as a triaging method to identify a fixed number of amyloid-positive individuals, this longitudinal voxel-wise classifier is expected to avoid 55% of unnecessary CSF and/or PET scans and reduce economic cost by 40%.
机译:磁共振成像(MRI)揭示了阿尔茨海默氏病(AD)病理生理连续体不同阶段的特定变化,这些变化已被确定为“ AD签名”。 MRI在多大程度上可以从认知能力未受损的人的结构MRI中检测出淀粉样蛋白相关的大脑变化,仍然是一个有待探索的领域。纵向3D-T1 MRI扫描是从ADNI队列的一个子集中获得的,该子集包含403位受试者:79位对照(Ctrls),50位临床前AD(PreAD)和274位MCI和AD引起的痴呆(MCI / AD)。淀粉样蛋白脑脊液被用作建立标准界限(2.5?年)的金标准量度,因此,仅使用该时间跨度内的受试者进行评估(15 Ctrls,10 PreAD)。纵向基于体素的分类器达到AUC?=?。 0.87(95%CI 0.72-0.97)。识别淀粉样蛋白异常的辨别力最高的大脑区域是内侧,下部和外侧颞叶;前突神经;尾状头;基底前脑;以及侧脑室。应用于纵向脑体积变化的机器学习可用于高精度地预测未受认知障碍的受试者中淀粉样蛋白异常的存在,作为一种分类方法来识别固定数量的淀粉样蛋白阳性个体,即纵向体素分类器有望避免55%的不必要的CSF和/或PET扫描,并将经济成本降低40%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号